Sophiris Bio
(SPHS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 9,721 | N/A | 22,150 |
| Receivables | N/A | N/A | 71 | N/A | 110 |
| Other current assets | 0 | 0 | 937 | 0 | 110 |
| TOTAL | $N/A | $N/A | $11,322 | $N/A | $22,370 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 163 | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 44 | 0 | 240 |
| TOTAL | $N/A | $N/A | $207 | $N/A | $240 |
| Total Assets | $N/A | $N/A | $11,529 | $N/A | $22,820 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 5,620 |
| Accounts payable and accrued liabilities | 0 | 0 | 1,774 | 0 | 3,230 |
| Accrued Expenses | N/A | N/A | 2,839 | N/A | 0 |
| TOTAL | $N/A | $N/A | $10,508 | $N/A | $8,850 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 6,126 | N/A | 8,710 |
| TOTAL | $N/A | $N/A | $6,126 | $N/A | $8,710 |
| Total Liabilities | $N/A | $N/A | $16,634 | $N/A | $17,570 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 54,215 | N/A | 54,490 |
| Retained earnings | N/A | N/A | -73,698 | N/A | -62,730 |
| Other shareholders' equity | 0 | 0 | 5,999 | 0 | 5,700 |
| TOTAL | $N/A | $N/A | $-5,105 | $N/A | $5,240 |
| Total Liabilities And Equity | $0 | $0 | $11,529 | $0 | $22,810 |